microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus

BMC Infectious Diseases

Volumn 14, Issue 5, 2014, Pages

  Bruni, Roberto ^a   Marcantonio, Cinzia ^a   Pulsoni, Alessandro ^b   Tataseo, Paola ^c   De Angelis, Federico ^b   Spada, Enea ^a   Marcucci, Fabrizio ^d   Panfilio, Sara ^b   Bianco, Paolo ^e   Riminucci, Mara ^e   Villano, Umbertina ^a   Tosti, Maria Elena ^a   Ciccaglione, Anna Rita ^a   Mele, Alfonso ^a,f  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ASL Avezzano Sulmona   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f ACE Associazione Calabrese di Epatologia   (Italy)

Author keywords

FFPE; Hepatitis B Virus; Hepatitis C Virus; Lymphoma; MicroRNA

Indexed keywords

MICRORNA; MICRORNA 223; MICRORNA 29A; MICRORNA 29B; MICRORNA 30B; MICRORNA 92A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC ASSOCIATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MALE; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; TISSUE LEVEL; UPREGULATION;

EID: 84977671331     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-S5-S6     Document Type: Article

References (45)

1. Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, Fukutomi M, Yokota M, Nishi H, Iwamoto H, Uike N, Nishimura J, Inaba S, Maeda Y, Nawata H, Muta K: Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol. 2001, 16: 215-219.
2. Iwata H, Matsuo K, Takeuchi K, Kishi Y, Murashige N, Kami M: High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus. Haematologica. 2004, 89 (3): 369-370.
3. Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Liso V, Andrizzi C, Pusterla S, Dore F, Maresca M, Rapicetta M, Marcucci F, Mandelli F, Franceschi S: Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood. 2003, 102 (3): 996-999.
4. Marcucci F, Mele A, Spada E, Candido A, Bianco E, Pulsoni A, Chionne P, Madonna E, Cotichini R, Barbui A, De Renzo A, Dore F, Iannitto E, Liso V, Martino B, Montanaro M, Pagano L, Musto P, Rapicetta M: High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica. 2006, 91: 554-557.
5. Hjalgrim H, Engels EA: Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med. 2008, 264 (6): 537-548.
6. Nath A., Agarwal R., Malhotra P., Varma S: Prevalence of Hepatitis B virus infection in Non-Hodgkin's lymphoma: a systematic review and meta-analysis. Intern Med J. 2010, 40 (9): 633-641.
7. Marcucci F, Mele A: Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood. 2011, 117 (6): 1792-1798.
8. Marcucci F, Spada E, Mele A, Caserta CA, Pulsoni A: The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res. 2012, 2 (1): 18-28.
9. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X: Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002, 347: 89-94.
10. Kelaidi C, Rollot F, Park S, Tulliez M, Christoforov B, Calmus Y, Podevin P, Bouscary D, Sogni P, Blanche P, Dreyfus F: Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia. 2004, 18: 1711-1716.
11. Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, Lazzaro A, Trabacchi E, Anselmi E, Arcari AL, Moroni C, Bertè R, Lazzarino M, Cavanna L: Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low grade, B-cell non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol. 2005, 23: 468-473.
12. Levine AM, Shimodaira S, Lai MM: Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon alfa. N Engl J Med. 2003, 349: 2078-2079.
13. Pontisso P, Vidalino L, Quarta S, Gatta A: Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev. 2008, 8 (1): 13-17.
14. Wang F, Yuan S, Teng KY, Garcia-Prieto C, Luo HY, Zeng MS, Rao HL, Xia Y, Jiang WQ, Huang HQ, Xia ZJ, Sun XF, Xu RH: High hepatitis B virus infection in B-cell lymphoma tissue and its potential clinical relevance. Eur J Cancer Prev. 2012, 21 (3): 261-267.
15. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116 (2): 281-297.
16. Filipowicz W, Bhattacharyya SN, Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet. 2008, 9: 102-114.
17. Wu L, Belasco JG: Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell. 2008, 29: 1-7.
18. Iorio MV, Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012, 4 (3): 143-159.
19. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 2009, 136: 215-233.
20. Cho WC: MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol. 2010, 42 (8): 1273-1281.
21. Doleshal M, Magotra AA, Choudhury B, Cannon BD, Labourier E, Szafranska AE: Evaluation and Validation of Total RNA Extraction Methods for MicroRNA Expression Analyses in Formalin-Fixed, Paraffin-Embedded Tissues. J Mol Diagn. 2008, 10 (3): 203-211.
22. Szafranska AE, Davison TS, Shingara J, Doleshal M, Riggenbach JA, Morrison CD, Jewell S, Labourier E: Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn. 2008, 10 (5): 415-423.
23. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, Ju J: Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA. 2007, 13 (10): 1668-1674.
24. Jopling CL, Yi MK, Lancaster AM, Lemon SM, Sarnow P: Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science. 2005, 309 (5740): 1577-1581.
25. Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, Nuovo G, Suzuki T, Croce CM, Patel T: Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes. Clin Cancer Res. 2010, 16: 957-966.
26. Bruni R, Marcantonio C, Tritarelli E, Tataseo P, Stellacci E, Costantino A, Villano U, Battistini A, Ciccaglione AR: An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones. BMC Genomics. 2011, 12: 485-
27. Peveling-Oberhag J, Crisman G, Schmidt A, Döring C, Lucioni M, Arcaini L, Rattotti S, Hartmann S, Piiper A, Hofmann WP, Paulli M, Küppers R, Zeuzem S, Hansmann ML: Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia. 2012, 26 (7): 1654-1662.
28. Huggett J, Dheda K, Bustin S, Zumla A: Real-time RT-PCR normalization; strategies and considerations. Genes Immun. 2005, 6 (4): 279-284.
29. Basso K, Sumazin P, Morozov P, Schneider C, Maute RL, Kitagawa Y, Mandelbaum J, Haddad J, Chen CZ, Califano A, Dalla-Favera R: Identification of the Human Mature B Cell miRNome. Immunity. 2009, 30 (5): 744-752.
30. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008, 26 (4): 462-469.
31. Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafà R, Magri E, Lunardi M, Munerato G, Querzoli G, Maestri I, Ulazzi L, Nenci I, Croce CM, Lanza G, Querzoli P, Negrini M: MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J Pathol. 2011, 225 (1): 43-53.
32. Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN: Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res. 2011, 17 (12): 4063-4070.
33. Liang Y, Ridzon D, Wong L and Chen C: Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007, 8: 166-
34. Arribas AJ, Campos-Martín Y, Gómez-Abad C, Algara P, Sánchez-Beato M, Rodriguez-Pinilla MS, Montes-Moreno S, Martinez N, Alves-Ferreira J, Piris MA, Mollejo M: Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets. Blood. 2012, 119 (3): e9-e21.
35. Robertus JL, Harms G, Blokzijl T, Booman M, de Jong D, van Imhoff G, Rosati S, Schuuring E, Kluin P, van den Berg A: Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Mod Pathol. 2009, 22 (4): 547-555.
36. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006, 103 (7): 2257-2261.
37. Mendell JT: miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008, 133 (2): 217-222.
38. Nilsson S, Möller C, Jirström K, Lee A, Busch S, Lamb R, Landberg G: Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration. PLoS One. 2012, 7 (4): e36051-
39. Wienholds E, Plasterk RH: MicroRNA function in animal development. FEBS Lett. 2005, 579: 5911-5922.
40. Santanam U, Zanesi N, Efanov A, Costinean S, Palamarchuk A, Hagan JP Volinia S, Alder H, Rassenti L, Kipps T, Croce CM, Pekarsky Y: Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci USA. 2010, 107: 12210-12215.
41. Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, Icardi MS, Brown KE, Burge CB, Schmidt WN, Wang Y, McCaffrey AP: Hepatitis C virus infection and hepatic stellate cell activation down-regulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis. 2011, 203 (12): 1753-1762.
42. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C, Bozzoni I: A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005, 123: 819-831.
43. Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y, Kawamura A, Nakamura K, Takeuchi T, Tanabe M: An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell. 2007, 129: 617-631.
44. Eyholzer M, Schmid S, Schardt JA, Haefliger S, Mueller BU, Pabst T: Complexity of miR-223 regulation by CEBPA in human AML. Leuk Res. 2009, 34 (5): 672-676.
45. Eyholzer M, Schmid S, Wilkens L, Mueller BU, Pabst T: The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br J Cancer. 2010, 103 (2): 275-284.